CANAQUEST PRESIDENT INTERVIEWED BY THE WALL STREET ANALYZER
TORONTO – January 19, 2021 − CANAQUEST MEDICAL CORP (OTC Markets: “CANQF”) (the “Company” or “CanaQuest”), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), is pleased to release a recent interview with […]
